At a Glance Commentary
======================

Scientific Knowledge on the Subject
-----------------------------------

Noninvasive mechanical ventilation (NIV) is increasingly used to assist spontaneous breathing during acute hypoxic *de novo* respiratory failure (AHRF), even though its potential therapeutic effect in this setting is controversial. Reported data show that NIV is used in 15% of patients with acute respiratory distress syndrome, irrespective of the severity of respiratory failure, and it seems to be associated with higher mortality in the case of failure. Several predictors of NIV failure in AHRF have been investigated but were found to be insufficient to aid the timing of endotracheal intubation. Thus, there is a need for an early robust predictor of NIV failure to avoid intubation delay.

What This Study Adds to the Field
---------------------------------

Our exploratory study shows that, in patients with moderate-to-severe AHRF who were candidates for a 24-hour NIV trial, the magnitude of inspiratory effort relief was an early and accurate predictor of NIV failure. Our study suggests that monitoring of esophageal pressure might assist clinicians in the timing of intubation for patients with AHRF undergoing a NIV trial.

The role of assisted spontaneous breathing (SB) in patients with acute hypoxic *de novo* respiratory failure (AHRF) is still controversial. When acute lung injury is mild, SB is desirable to preserve respiratory muscle function, improve the $\overset{.}{V}/\overset{.}{Q}$ ratio and regional ventilation ([@bib1]), and reduce sedation and days of invasive mechanical ventilation (MV) ([@bib2]). On the other hand, recent studies have suggested that SB might be a potential mechanism for lung damage if acute respiratory distress is severe ([@bib3]). In recent years, noninvasive MV (NIV) has been increasingly used to assist SB in the intensive care setting, even though its potential therapeutic effect in AHRF is still debated. It has been reported that NIV is used in 15% of patients with acute respiratory distress syndrome (ARDS), irrespective of the severity of respiratory failure, and it seems to be associated with higher mortality when the Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio is \<150 mm Hg ([@bib4]). Moreover, some studies have shown that NIV failure is associated with increased mortality in patients with AHRF ([@bib4], [@bib5]); however, when NIV treatment is successful, it might considerably reduce the risk of death and length of ICU stay in this subset of patients ([@bib5]).

Despite the fact that several potential factors associated with NIV failure have been investigated in patients with hypoxia, there are no robust predictors that might alert the intensivist to the need for endotracheal intubation (ETI) within the very first hours of ventilation ([@bib6]). Although the mechanisms behind the association between NIV failure and poorer survival remain unclear, a potential role for SB might be hypothesized. When SB is preserved during AHRF, the intensity of inspiratory effort may follow a critical increase in respiratory drive, thus producing uncontrolled tidal change in dynamic transpulmonary pressure (ΔP[l]{.smallcaps}) that would increase the risk of injury to the dependent lung and predispose the patient to the onset of self-inflicted lung injury (SILI) ([@bib6]). The underlying mechanisms of SILI are heterogeneous and include the pendelluft phenomenon, increased transvascular pressure gradient aggravating alveolar damage, excessive diaphragmatic loading with impaired systemic oxygen delivery, and muscle injury ([@bib3], [@bib7]--[@bib9]).

In this study, we explore the hypothesis that, in patients with moderate or severe AHRF undergoing a NIV trial, the excessive spontaneous effort of the patients, measured with tidal change in esophageal pressure (ΔPes), may be a major determinant of NIV failure at 24 hours.

Methods
=======

Study Population
----------------

This prospective observational cohort study was performed in a single eight-bed respiratory ICU (RICU) at the University Hospital of Modena, Italy, after approval from the Ethics Committee *Area Vasta Emilia Nord* (registered protocol number 4485/C.E., document 266/16). After testing our study hypothesis in four patients (pilot data not included in the analysis) during the period from October 2016 to December 2018, the study was registered retrospectively on [clinicaltrials.gov](http://clinicaltrials.gov) (NCT 03826797). Thirty consecutive patients were then enrolled in between February and October of 2019. Written informed consent to participate in the study and to analyze and divulgate clinical data was obtained from all patients admitted.

Inclusion criteria were age \> 18 years; the presence of AHRF with a Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio \< 200 mm Hg, despite high-flow nasal oxygen with the flow set at 60 L/min; and candidate's approval for receiving a NIV trial by the attending RICU staff, whose decision was made upon clinical conditions being blinded to the purpose of the study. Patients were excluded in the case of a previously established diagnosis of chronic obstructive pulmonary disease, pulmonary embolism, neuromuscular disease, cardiogenic acute pulmonary edema, interstitial lung disease, or chest-wall deformities or the need for immediate ETI as represented by any of the following: cardiopulmonary arrest, respiratory arrest, loss of consciousness with respiratory pauses, psychomotor agitation requiring sedation, pH \< 7.20, neurological deterioration or massive secretions, hemodynamic instability or major electrocardiographic abnormalities, pregnancy, intolerance to NIV, hypercapnic respiratory failure of any etiology (Pa~CO~2~~ \> 45 mm Hg), home long-term oxygen therapy, or denial of informed consent.

General Measures
----------------

Demographics and relevant comorbidities were assessed on admission. Clinical severity as assessed by the Kelly Scale, the Acute Physiology and Chronic Health Evaluation II score, the Simplified Acute Physiology Score, the Subsequent Organ Failure Assessment score, and the Heart Rate, Acidosis, Consciousness, Oxygenation and Respiratory Rate (HACOR) score were assessed and recorded on admission and after 2, 4, 12, and 24 hours. Arterial blood gases (Pa~O~2~~ and Pa~CO~2~~), pH, Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, respiratory rate (RR), and blood lactate values were recorded before NIV start and 2, 4, 12, and 24 hours later. A chest X-ray was taken on admission and 24 hours after NIV start.

Physiological Measurements
--------------------------

A multifunctional nasogastric tube with a dedicated pressure transducer (NutriVent; Sidam Group) was placed before starting NIV. The nasogastric tube was connected to a dedicated monitoring system (OptiVent; Sidam Group) to record ΔPes and ΔP[l]{.smallcaps}. To avoid using absolute values for Pes and P[l]{.smallcaps}, we always refer to ΔPes and ΔP[l]{.smallcaps} from the end-expiratory amounts ([@bib10]). Appropriate catheter position was confirmed by visualization of cardiac artifacts on Pes traces and radiopaque markers on chest X-rays, and validation of Pes measurements was obtained through dynamic occlusion tests ([@bib11], [@bib12]). ΔPes was calculated as the negative deflections of Pes from the onset of inspiratory effort. ΔP[l]{.smallcaps} was calculated as airway pressure minus Pes ([@bib10]).

ΔPes, ΔP[l]{.smallcaps}, and ΔPes/ΔP[l]{.smallcaps} ratios were assessed on admission and 2, 4, 12, and 24 hours after NIV start. Initial measurements were performed at each prespecified time point while the patient was breathing spontaneously through the ventilator circuit. Data were sampled at 100 Hz and processed on a dedicated data acquisition system (OptiVent; Sidam Group) ([@bib12]). Data sampling was numerically stored and downloaded via a universal-serial-bus stick at each time of assessment. Offline breath-by-breath analysis was then performed for each measurement and then averaged by a specific software (Flux View Respiratory Mechanics Monitor \[Medical Graphics\]). For all the measurements, the beginning of the inspiratory phase was identified at the instant of Pes initial decay, whereas the end of inspiration was considered as the point of Pes at which 25% of the time from maximum deflection to return to baseline had elapsed.

Respiratory flow was measured by an external heated Fleisch No. 2 pneumotachograph (Fleisch) inserted between the patient's oronasal facemask (Bluestar; KOO Medical Equipment) and a connector with a side port for mechanical measurement. Expiratory V[t]{.smallcaps} (V[t]{.smallcaps}e) was obtained by numerical integration of the flow signal. V[t]{.smallcaps}e was then adjusted to the predicted body weight (PBW) to derive V[t]{.smallcaps}e/kg of PBW. V[t]{.smallcaps}e/kg of PBW was assessed on admission and 2, 4, 12 and 24 hours after NIV start. $\overset{˙}{\text{V}}$[e]{.smallcaps} was calculated as the product of V[t]{.smallcaps}e and RR and assessed on admission and 2, 4, 12 and 24 hours after NIV start. The V[t]{.smallcaps}e/ΔP~L~ ratio was further measured at each predefined time point.

Leaks from the oronasal facemask were computed using dedicated ventilator-integrated software (GE Healthcare Engstrom Carestation; GE Healthcare) on the basis of the following equation: leaks (L/min) = (inspiratory V[t]{.smallcaps} − V[t]{.smallcaps}e) × RR.

All measurements were performed during a stable SB pattern of 5 minutes, and results were averaged for each assessment step.

NIV Treatment
-------------

After Nutrivent placement, NIV was started and set by a respiratory physician with expertise in respiratory intensive care. Patients were connected via a conventional circuit with an appropriately sized oronasal facemask equipped with a dedicated output for probes (Bluestar; KOO Medical Equipment) to a high-performance ventilator (GE Healthcare Engstrom Carestation; GE Healthcare) in pressure-support preset mode. A heat and moisture exchanger (Hygrobac; DAR) was placed to the ventilator circuit's Y-piece. Positive end-expiratory pressure (PEEP) was initially set at 6 cm H~2~O and subsequently fine-tuned (4--8 cm H~2~O) to target a Sa~O~2~~ \> 92% with a delivered F[i]{.smallcaps}~O~2~~ \< 70%. Pressure support was set at 10 cm H~2~O and then progressively modified according to V[t]{.smallcaps} (V[t]{.smallcaps}e/kg of PBW) to target a V[t]{.smallcaps}e/kg of PBW \< 9.5 ml/kg of PBW and an RR \< 30 breaths/min (bpm). The oronasal facemask was finely adjusted to target a leak flow \< 20 L/min. The inspiratory trigger was set at 3 L/min, and respiratory cycling was set at 25% of the inspiratory peak flow. Great care was taken by the nurses in charge of NIV, who were blinded to the protocol, to avoid any possible air leaks. The inspiratory F[o]{.smallcaps}~2~ delivered (F[i]{.smallcaps}~O~2~~) was increased to target a transcutaneous oxyhemoglobin saturation of 88--94%. The setting was adjusted by the attending physician blinded to the study purpose on the basis of blood gases and/or continuous oxymetry assessment. Patients receiving NIV treatment were not sedated. The decision as to whether to proceed to ETI at 24 hours after NIV start was made according to best clinical practice by the attending RICU staff, who were blinded to the results of the physiological assessment acquired through the Optivent monitor only at each predefined time point. NIV failure was defined by the onset of the need for ETI or by death. Criteria for ETI included *1*) Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio unchanged or worsened or \<150 mm Hg, *2*) the need to protect airways because of neurological deterioration or massive secretions, *3*) hemodynamic instability or major electrocardiographic abnormalities, and *4*) unchanged or worsened dyspnea and persistence of respiratory distress (RR \> 35 bpm, gasping for air, psychomotor agitation requiring sedation, or abdominal paradox).

Outcome Measures
----------------

The influence of ΔPes on NIV failure or success at 24 hours was prespecified as a primary outcome. The impact of ΔP[l]{.smallcaps}, ΔPes/ΔP[l]{.smallcaps} ratio, Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, RR, V[t]{.smallcaps}e/kg of PBW, V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio, $\overset{˙}{\text{V}}$[e]{.smallcaps}, and the HACOR score on NIV outcome at 24 hours and the correlation between ΔPes and radiographic changes on chest X-ray within the first 24 hours after NIV start were assessed as secondary outcomes. Radiographic changes on chest X-ray within the first 24 hours after admission were assessed by a radiologist with expertise in chest X-ray who was blinded to the purpose of the study. Changes were classified as follows: relevant worsening, worsening, mild worsening, unmodified, relevant improvement, improvement, and mild improvement.

Statistical Analysis
--------------------

The statistical package GraphPad Prism 8.0 (GraphPad Software) was used for statistical analysis. Because of the exploratory nature of the study, no sample size calculation was performed. Descriptive statistics were used to characterize the study population as a whole and according to primary outcome. The nonparametric Mann-Whitney and Student's *t* tests were used for the comparison of continuous variables. Comparison between dichotomous variables was performed by the χ^2^ test or Fisher exact test, when appropriate. The time course of ΔPes, ΔP[l]{.smallcaps}, ΔPes/ΔP[l]{.smallcaps} ratio, Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, V[t]{.smallcaps}e/kg of PBW, V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio, RR, $\overset{˙}{\text{V}}$[e]{.smallcaps}, and HACOR score according to NIV outcome within the first 24 hours of treatment was assessed through ANOVA analysis. Then, a *post hoc* Bonferroni-Dunn multiple test was used to perform the pairwise comparison of means for each analyzed variable at the prespecified time points. The correlation between baseline values of ΔPes and Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, V[t]{.smallcaps}e, RR, HACOR score, V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio, and the chest X-ray radiographic categories was assessed through Pearson correlation coefficient. The impact of ΔPes within 2 hours after NIV start and the baseline value of V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio on NIV outcome was assessed through a logistic regression model. A receiver operating characteristic (ROC) analysis was then performed to identify the best predictive cutoff for ΔPes within 2 hours after NIV start and for baseline V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio. The association between the best cutoff value of ΔPes after 2 hours of NIV and baseline V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio, V[t]{.smallcaps}e \> 9.5 ml/kg of PBW, RR \> 30 bpm, Pa~O~2~/~F[i]{.smallcaps}~O~2~~ ratio \< 150 mm Hg, and HACOR score \> 5 within 2 hours after NIV start on NIV failure at 24 hours was then tested through univariate logistic regression analysis. ROC analysis was used to assess the accuracy in predicting NIV failure at 24 hours for all the analyzed variables at prespecified cutoffs. Then, at 30 days, survival analysis was performed through a log-rank test for ΔPes within 2 hours after NIV start. A *P* value \< 0.05 was considered to be statistically significant.

Results
=======

Patient Characteristics
-----------------------

Over the study period, 30 out of 86 consecutive patients admitted for AHRF to the RICU of the University Hospital of Modena (Italy) and who were candidates to receive a NIV trial were enrolled in this study. Of these, 12 patients (40%) experienced NIV failure within 24 hours after NIV start. Those patients for whom the need for ETI was defined at 24 hours as the "alert" criterion of our internal guideline were thereafter intubated by the RICU staff. Of those who were successful in the 24-hour trial (60%), none were further intubated during their RICU stay. The flowchart for patients in this study is shown in [Figure 1](#fig1){ref-type="fig"}.

![Flowchart for patients in this study. ΔPes = tidal change in esophageal pressure; ΔP[l]{.smallcaps} = tidal change in transpulmonary pressure; DRF = *de novo* respiratory failure; IOT = intubation (orotracheal); MV = mechanical ventilation; NIV = noninvasive MV; NM = neuromuscular; RICU = respiratory ICU.](rccm.201912-2512OCf1){#fig1}

The general features and clinical characteristics of the whole population at baseline and according to NIV outcome at 24 hours are presented in [Table 1](#tbl1){ref-type="table"}. None of the features assessed were significantly different between the two groups of patients (NIV failure vs. NIV success) at baseline. In particular, the overall population presented an average Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio value of 125 (interquartile range \[IQR\], 101--170) mm Hg, which did not differ significantly according to NIV outcome at 24 hours (100 \[118--141\] mm Hg and 111 \[132--173\] mm Hg, respectively; *P* = 0.5). All patients with ARDS (*n* = 15) presented pulmonary ARDS. In 10 patients, the etiology was identified as infectious (bacterial, *n* = 4; fungal, *n* = 2; and viral, *n* = 4), whereas, for five patients, no etiological diagnosis was made. Patients with pneumonia had unilateral lung consolidation, and nine of them presented a bacterial infectious cause (*Streptococcus pneumoniae*, *n* = 4; intracellular pathogens, *n* = 4; and *Hemophilus influenzae*, *n* = 1). The presence of pneumonia and ARDS was equally distributed between the two groups (42% vs. 44%, *P* \> 0.9 and 58% vs. 44%, *P* = 0.7, respectively).

###### 

Baseline Features of the Study Population Presented as a Whole or as NIV Outcome at 24 Hours

  Feature                                              Overall           NIV Failure        NIV Success      *P* Value
  ---------------------------------------------- ------------------- ------------------- ------------------ -----------
  Number of patients                                     30                  12                  18             ---
  Age, yr                                            71 (66--81)         69 (62--80)        71 (68--81)         0.7
  Sex, M                                               20 (67)             8 (67)             12 (67)          \>0.9
  BMI, kg/m^2^                                       23 (19--27)        22.5 (18--26)       24 (21--27)         0.3
  Charlson index score                               4 (3--5.5)           4 (3--5)           4.5 (3--6)         0.6
  Pneumonia                                            13 (23)             5 (42)              8 (44)          \>0.9
  ARDS                                                 15 (50)             7 (58)              8 (44)           0.7
  Kelly scale score                                   1 (1--1)            1 (1--1)            1 (1--1)          0.4
  APACHE II score                                    27 (21--38)        24.5 (19--45)       28 (25--37)         0.8
  SAPS II score                                      36 (26--41)         36 (31--38)        36 (25--44)         0.6
  SOFA score                                         6 (4--8.8)          5.5 (3--8)          6.5 (4--9)         0.6
  Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, mm Hg     125 (101--170)      118 (100--141)      133 (111--144)       0.5
  pH                                              7.48 (7.44--7.51)   7.49 (7.46--7.52)   7.48 (7.44--7.5)      0.2
  Pa~CO~2~,~ mm Hg                                   35 (30--40)         34 (30--37)        36 (30--42)         0.2
  Blood lactate, mg/dl                               27 (14--40)         30 (18--40)        25 (12--40)         0.7
  Serum creatinine, mg/dl                          0.68 (0.5--0.9)     0.6 (0.5--0.7)     0.8 (0.65--0.8)       0.4
  PEEP, cm H~2~O                                     8 (6.5--10)         8 (7.5--10)         8 (6--10)          0.7
  PS, cm H~2~O                                       10 (10--14)         11 (10--12)        11 (10--14)         0.3

*Definition of abbreviations*: APACHE II = Acute Physiology and Chronic Health Evaluation II; ARDS = acute respiratory distress syndrome; BMI = body mass index; NIV = noninvasive mechanical ventilation; PEEP = positive end-expiratory pressure; PS = pressure support; SAPS II = Simplified Acute Physiology Score; SOFA = Subsequent Organ Failure Assessment.

Data are presented as *n* (%) for dichotomous values or median (interquartile range) for continuous values unless otherwise specified.

Physiological Measurements and NIV Outcome
------------------------------------------

[Table 2](#tbl2){ref-type="table"} shows the physiological dynamic respiratory mechanics for the whole population at baseline and in the NIV outcome subgroups at baseline and after 2 hours of NIV. At baseline, the median (IQR) value of ΔPes was 34 (26--40) cm H~2~O. Of note, none of the physiological features analyzed were significantly different at baseline between the two groups. After 2 hours of NIV, the median (IQR) value of ΔPes was significantly lower for those patients who had a successful outcome in the 24-hour NIV trial compared with patients who had NIV failure: 11 (8--15) cm H~2~O versus 31.5 (30--36) cm H~2~O (*P* \< 0.0001). Moreover, these latter patients presented a significantly increased value of ΔP[l]{.smallcaps} once NIV had started compared with patients who experienced NIV success at 24 hours (median \[IQR\], 39.5 \[37.5--42--3\] cm H~2~O vs. 30.5 \[28--43.5\] cm H~2~O; *P* = 0.04).

###### 

Clinical and Physiological Features of the Study Population at Baseline and after 2 Hours of NIV

  Feature                                                                Overall           NIV Failure         NIV Success      *P* Value
  ---------------------------------------------------------------- ------------------- ------------------- ------------------- -----------
  Baseline RR, bpm                                                     36 (27--44)         34 (27--42)         36 (27--45)         0.8
  RR after 2 h of NIV, bpm                                             30 (24--37)         31 (25--37)         30 (24--37)         0.6
  Baseline ΔP[l]{.smallcaps} (ΔPes), cm H~2~O                          35 (26--40)         38 (32--42)        32.5 (24--39)        0.1
  ΔPes after 2 h of NIV, cm H~2~O                                    19.5 (12.5--31)      31.5 (30--36)        11 (8--15)       \<0.0001
  ΔP[l]{.smallcaps} after 2 h of NIV, cm H~2~O                         37 (30--43)      39.5 (37.5--42.3)    30.5 (28--43.5)      0.04
  Baseline $\overset{˙}{\text{V}}$[e]{.smallcaps}, L/min            28.1 (25.6--34.7)   28.3 (25.8--32.3)   27.4 (22.2--28.9)      0.6
  $\overset{˙}{\text{V}}$[e]{.smallcaps} after 2 h of NIV, L/min    23.3 (18.2--27.3)    27.2 (25--27.8)     19.8 (16.5--25)      0.07
  Baseline V[t]{.smallcaps}e, ml/kg of PBW                             11 (9--12)        11 (9.5--12.3)      10.9 (9--11.2)        0.7
  V[t]{.smallcaps}e after 2 h of NIV, ml/kg of PBW                     11 (10--12)        11 (10--12.3)      10.8 (8.5--12)        0.5
  Baseline V[t]{.smallcaps}e/ΔP~L~ ratio, ml/kg/cm H~2~O            0.32 (0.28--0.57)   0.31 (0.29--0.57)   0.33 (0.27--0.4)       0.3
  V[t]{.smallcaps}e/ΔP~L~ ratio after 2 h of NIV, ml/kg/cm H~2~O    0.31 (0.25--0.39)   0.36 (0.21--0.44)   0.29 (0.26--0.31)      0.1
  HACOR score                                                           6 (5--8)          6.5 (4.8--8)          6 (6--7)           0.5
  HACOR score after 2 h of NIV                                          6 (5--6)          6 (4.8--6.5)         5.5 (4--6)          0.4

*Definition of abbreviations*: bpm = breaths/min; ΔPes = tidal change in esophageal pressure; ΔP[l]{.smallcaps} = tidal change in dynamic transpulmonary pressure; HACOR = Heart Rate, Acidosis, Consciousness, Oxygenation and Respiratory Rate; NIV = noninvasive mechanical ventilation; PBW = predicted body weight; RR = respiratory rate; V[t]{.smallcaps}e = expiratory V[t]{.smallcaps}.

Data are presented as median (interquartile range).

[Figure 2A](#fig2){ref-type="fig"} shows ΔPes from baseline within the first 2 hours of NIV for the whole population and according to NIV outcome at 24 hours. ΔPes decreased significantly after 2 hours of NIV for the whole population and for those patients who were successful in the NIV trial, whereas it did not change for patients who experienced NIV failure. Moreover, only these latter patients presented a significant increase in ΔP[l]{.smallcaps} after 2 hours of NIV ([Figure 2B](#fig2){ref-type="fig"}).

![(*A*) ΔPes changes from baseline within the first 2 hours of NIV for the whole population and according to NIV outcome at 24 hours. (*B*) ΔP[l]{.smallcaps} changes from baseline within the first 2 hours of NIV for the whole population and according to NIV outcome at 24 hours. ΔPes = tidal change in esophageal pressure; ΔP[l]{.smallcaps} = tidal change in transpulmonary pressure; NIV = noninvasive mechanical ventilation.](rccm.201912-2512OCf2){#fig2}

Waveform analysis of ΔP[l]{.smallcaps} and ΔPes 2 hours after NIV start is displayed in [Figure 3](#fig3){ref-type="fig"} for a patient who had NIV failure in the 24-hour trial ([Figures 3A and 3C](#fig3){ref-type="fig"}) and for a patient who had NIV success ([Figures 3B and 3D](#fig3){ref-type="fig"}). The time course of the physiological and clinical variables (ΔPes, ΔP[l]{.smallcaps}, ΔPes/ΔP[l]{.smallcaps} ratio, RR, Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, HACOR score, V[t]{.smallcaps}e/kg of PBW, V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio, and $\overset{˙}{\text{V}}$[e]{.smallcaps}) in the two categories of patients according to NIV outcome showed a significant improvement over time in patients who were successful in the NIV trial. Moreover, only ΔPes significantly decreased earlier (2 h after NIV start) in those patients who were successful in the NIV trial compared with those who failed (*P* \< 0.0001, *see* Figure E1A in the online supplement). The ratio between ΔPes and ΔP[l]{.smallcaps} was significantly different 2 hours after NIV start between the two groups (*P* \< 0.0001, Figure E1C), whereas ΔP[l]{.smallcaps} (*P* = 0.04, Figure E1B), V[t]{.smallcaps}e/kg of PBW, $\overset{˙}{\text{V}}$[e]{.smallcaps}, V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio (*P* = 0.01, *P* = 0.01, and *P* = 0.001; Figure E2A--E2C, respectively), RR, Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, HACOR score (*P* = 0.02, *P* \< 0.0001, and *P* = 0.0; Figure E3A--E3C, respectively) were all significantly different more than 2 hours after NIV start.

![Graphical representation of ΔP[l]{.smallcaps} and ΔPes waveform swings after 2 hours of NIV for (*A* and *C*) a patient who had failure in the noninvasive mechanical ventilation trial at 24 hours and for (*B* and *D*) a patient who had success. The beginning of the inspiratory phase was identified at the time of Pes initial decay, whereas the end of inspiration was considered at the point of Pes that elapsed 25% of time from its maximum deflection to return to baseline. ΔPes = tidal change in esophageal pressure; ΔP[l]{.smallcaps} = tidal change in dynamic transpulmonary pressure.](rccm.201912-2512OCf3){#fig3}

Significant inverse correlation was found between baseline ΔPes and V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio (*r* = −077, *P* \< 0.0001, Figure E4). No significant correlation was found between baseline ΔPes and Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio (*r* = −0.01, *P* = 0.9, Figure E5A), RR (*r* = 0.23, *P* = 0.2, Figure E5B), HACOR score (*r* = 0.05, *P* = 0.8, Figure E5C), and V[t]{.smallcaps}e/kg of PBW (*r* = −0.05, *P* = 0.8, Figure E5D).

Radiological Changes and Inspiratory Effort
-------------------------------------------

The correlation analysis performed for radiographic changes showed that patients with a greater reduction in ΔPes 2 hours after NIV start experienced more consistent improvements on chest X-ray at 24 hours, whereas patients with a limited reduction of ΔPes were those who showed a deterioration on chest X-ray (Figure E6).

Inspiratory Effort and Clinical Outcome
---------------------------------------

In the logistic regression model, ΔPes changes within the first 2 hours of NIV showed a significant association with NIV failure at 24 hours (odds ratio \[OR\], 1.7; 95% confidence interval \[CI\], 1.2--3; *P* = 0.01), whereas the baseline V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio was not significantly associated with NIV outcome (*P* = 0.03). From ROC analysis, ΔPes changes \< 10 cm H~2~O gave the most accurate cutoff value for prediction of NIV failure (sensitivity, 0.91; 95% CI, 0.65--1 and specificity, 0.83; 95% CI, 0.61--0.94; likelihood ratio, 5.5; positive predictive value, 0.79; 95% CI, 0.52--0.92; negative predictive value, 0.94; 95% CI, 0.72--1; Table E1); a V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio \< 0.33 ml/kg/cm H~2~O showed the best cutoff value for prediction of NIV failure (sensitivity, 0.67; 95% CI, 0.40--0.86 and specificity, 0.5; 95% CI, 0.29--0.71; likelihood ratio, 1.3; positive predictive value, 0.47; 95% CI, 0.26--0.7; negative predictive value, 0.7; 95% CI, 0.42--87; Table E2). When univariate logistic regression was applied to the prespecified potential predictors of NIV failure, ΔPes \< 10 cm H~2~O showed the highest association with NIV failure at 24 hours (OR, 15; 95% CI, 2.8--110; *P* = 0.001). Among the other predictors tested, V[t]{.smallcaps}e \> 9.5 ml/kg of PBW and HACOR \> 5 after 2 hours of NIV were significantly associated with NIV failure at 24 hours (OR, 7.9; 95% CI, 1.5--72; *P* = 0.02 and OR, 6.3; 95% CI, 0.9--49; *P* = 0.046, respectively), whereas RR \> 30 bpm, Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio \< 150 mm Hg, and V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio \< 0.33 ml/kg/cm H~2~O, although strongly associated, did not reach statistical significance ([Table 3](#tbl3){ref-type="table"}). From ROC analysis, ΔPes \< 10 cm H~2~O within the first 2 hours after NIV start showed higher accuracy in predicting NIV failure (area under the curve \[AUC\], 0.97; 95% CI, 0.91--1; *P* \< 0.0001) ([Figure 4](#fig4){ref-type="fig"}) than baseline V[t]{.smallcaps}e \> 9.5 ml/kg of PBW(AUC, 0.88; 95% CI, 0.76--0.99; *P* = 0.0005), HACOR score \> 5 (AUC, 0.85; 95% CI, 0.71--0.99; *P* = 0.00), RR \> 30 bpm (AUC, 0.83; 95% CI 0.67--0.98; *P* = 0.003) Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio \< 150 mm Hg (AUC, 0.74; 95% CI, 0.56--0.92; *P* = 0.03), and V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio \< 0.33 ml/kg/cm H~2~O (AUC, 0.58; 95% CI, 0.37--0.8; *P* = 0.44).

###### 

Association between Physiological and Clinical Variables and NIV Failure at 24 Hours

  Feature                                                             OR     95% CI    *P* Value
  ------------------------------------------------------------------ ----- ---------- -----------
  ΔPes \< 10 cm H~2~O post 2 h NIV                                    15    2.8--110     0.001
  V[t]{.smallcaps}e \> 9.5 ml/kg of PBW                               7.9   1.5--72      0.02
  HACOR score \>5 post 2 h NIV                                        6.3   0.9--49      0.046
  RR \> 30 bpm                                                        5.5   0.8--112     0.14
  Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio \< 150 mm Hg                   2    0.5--9.8      0.4
  V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio \< 0.33 ml/kg/cm H~2~O     2    0.4--9.8     0.36

*Definition of abbreviations*: bpm = breaths/min; CI = confidence interval; ΔPes = tidal change in esophageal pressure; ΔP[l]{.smallcaps} = tidal change in dynamic transpulmonary pressure; HACOR = Heart Rate, Acidosis, Consciousness, Oxygenation and Respiratory Rate; NIV = noninvasive mechanical ventilation; OR = odds ratio; PBW = predicted body weight; RR = respiratory rate; V[t]{.smallcaps}e = expiratory V[t]{.smallcaps}.

![Receiver operating characteristic analysis. Tidal change in esophageal pressure changes \< 10 cm H~2~O within the first 2 hours of noninvasive mechanical ventilation showed a high accuracy in predicting noninvasive mechanical ventilation failure (AUC, 0.97; *P* \< 0.0001). AUC = area under the curve; CI = confidence interval.](rccm.201912-2512OCf4){#fig4}

Kaplan-Meier curves showed a significant increase in 30-day mortality among patients with ΔPes reduction \< 10 cm H~2~O within the first 2 hours after NIV start compared with patients with a more consistent early improvement (hazard ratio, 4.5; 95% CI, 1.01--17.9; *P* = 0.048; Figure E7).

Discussion
==========

In this exploratory study, patients with moderate-to-severe AHRF undergoing a NIV trial presented a median baseline value for ΔPes of 34 cm H~2~O that was significantly reduced within the first 2 hours of ventilation in patients who were successful in the NIV trial, whereas those patients failing the NIV trial did not have a significantly reduced ΔPes. This study therefore shows that a significant ΔPes reduction within the first 2 hours of NIV start was an early and accurate predictor of NIV outcome and was significantly correlated with radiographic changes after 1 day of NIV. Moreover, the magnitude of inspiratory effort at baseline did not show a significant correlation with the severity of respiratory failure, V[t]{.smallcaps}, RR, or HACOR score on admission.

Physiological Measurements and NIV Outcome
------------------------------------------

### Early prediction of NIV failure in AHRF

The application of NIV in treating patients with AHRF is a controversial issue and it is currently used in clinical practice, irrespective of the severity of the Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio. Despite the initial promising results on the effectiveness of NIV in patients with hypoxic respiratory failure ([@bib13], [@bib14]), more recent studies focusing on patients with AHRF and excluding underlying chronic respiratory diseases or cardiogenic pulmonary edema warn of the increased mortality rates once ETI is delayed ([@bib5], [@bib15], [@bib16]). Despite the fact that failure rates can exceed 60% in patients with more severe AHRF, successful application of NIV is independently associated with survival and shorter length of ICU stay ([@bib5]). Giving these assumptions, it seems of critical interest to identify early predictors of NIV failure to avoid deleterious intubation delay in this subset of patients.

Previous studies have shown that several factors (i.e., higher severity score on admission, older age, ARDS or pneumonia as the etiology for acute respiratory failure, or a lack of improvement in blood gas exchange within 1 h of treatment) are associated with NIV failure in patients with AHRF, although these were insufficient to influence ETI timing ([@bib17]). In our study, none of these factors were different in patients who had 24-hour NIV failure compared with patients who had NIV success. In a recent single-center study, Duan and coworkers ([@bib18]) developed and validated the HACOR score for prediction of NIV failure in patients with AHRF, showing that patients with a HACOR score \> 5 after the first hour of NIV were at greater risk for NIV failure and, if switched to invasive MV within the first 12 hours, presented reduced in-hospital mortality. In our study, the HACOR score was significantly associated with increased NIV failure but not as early as ΔPes. Moreover, both groups of patients presented a HACOR score \> 5 after the first 2 hours of NIV. Two recent studies have demonstrated that moderate-to-severe hypoxemia significantly affects NIV outcome in patients with ARDS-induced AHRF ([@bib19], [@bib20]). Our study presented a carefully selected population of patients with moderate-to-severe AHRF, whose average Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio was 132 mm Hg and in whom significant differences between those who had success in the NIV trial and those who were subjected to ETI did not become evident until 12 hours after the start of NIV. Of interest, the inspiratory effort at baseline as expressed by ΔPes did not show a significant correlation with the severity of respiratory failure. These findings are in line with data reported in a recent physiological study by Grieco and colleagues ([@bib21]), in which ΔPes was unrelated to oxygenation impairment during helmet NIV and high-flow oxygen treatment. Our data further underline the inability of Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio alone to identify patients with harmful respiratory drive.

In a recent trial, Carteaux and coworkers ([@bib22]) showed that a V[t]{.smallcaps}e value \> 9.5 ml/kg was independently associated with NIV failure in patients with AHRF, suggesting a role of high V[t]{.smallcaps}e as a potential predictor of NIV failure in this setting ([@bib19]). The results from our study are in line with their reported data, although significant differences in V[t]{.smallcaps}e between patients who had NIV treatment failure and those who had treatment success became evident 12 hours after NIV start. Moreover, the magnitude of inspiratory effort was not correlated with average V[t]{.smallcaps}e at baseline. Considering these data, the inability to apply protective ventilation should be considered a critical mechanism of NIV failure in this subset of patients.

The main result from our study was that a change in ΔPes \< 10 cm H~2~O within the first 2 hours after NIV start was an early and accurate predictor of NIV failure at 24 hours when compared with other variables, such as Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio, V[t]{.smallcaps}e, HACOR, and RR. From a clinical point of view, these data might suggest that, in patients with moderate-to-severe AHRF, the effectiveness of a NIV trial should be related to the reduction in the patient's inspiratory effort, which is quantifiable through esophageal manometry. The consequences of this reduction translate into a subsequent significant reduction of V[t]{.smallcaps}e, a decrease in RR, and an improvement in Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio with a few hours' latency. Moreover, the correlation analysis showed that ΔPes on admission was not associated with the baseline value of other predictors of NIV failure.

Radiological Changes and Inspiratory Effort
-------------------------------------------

### Inspiratory effort and SILI during NIV

Our results showed a significant correlation between ΔPes changes within the first 2 hours of NIV and radiographic progression at 24 hours. Despite being less accurate than a computed tomography scan, chest X-rays showed good sensitivity in detecting lung alteration in patients with ARDS ([@bib23]) and might be considered reliable in the evaluation of the extent and distribution of lung opacities, once a diagnosis has already been made ([@bib24]).

The results of our study support the hypothesis that inspiratory effort might be a potential mechanism of lung damage enhancement if acute respiratory distress is severe. Although data from animal models indicate ΔP[l]{.smallcaps} as a major determinant of SILI, experimental studies conducted on normal trained subjects during exhausting endurance exercise demonstrated that potentially injurious values of ΔP[l]{.smallcaps} (up to 52 cm H~2~O) did not translate into lung mechanical changes ([@bib25], [@bib26]). To understand this, we have to consider that in normal fluid-like lung, the inspiratory swing in pleural pressure produced by inspiratory effort is homogeneously distributed across the pleural surface. In contrast, in injured solid-like lung, the inspiratory pleural swing is not uniformly dissipated, resulting in a more negative deflection in the dependent lung zones with tidal overrecruitment and local overstretch ([@bib6]). More recently, two trials investigating the role of assisted SB in mechanically ventilated patients showed that SB was not associated with a poorer outcome when compared with controlled MV ([@bib27], [@bib28]), but they lacked an assessment of the inspiratory effort. Our results might suggest that a major determinant in generating lung stress lies in the dynamic component of the inspiratory effort rather than in the absolute value of the pressure generated. Interestingly, within the first 2 hours of NIV, the ΔPes/ΔP[l]{.smallcaps} ratio was different in those who were successful in the NIV trial compared with those who failed it. This ratio might express to what extent dynamic ΔP[l]{.smallcaps} is affected by the patient's respiratory drive and might introduce a new insight in the understanding of SILI. In particular, for the same value of ΔP[l]{.smallcaps}, patients who presented higher values of ΔPes experienced a higher NIV failure rate. This mechanism, alongside a V[t]{.smallcaps} \> 6 ml, high breathing frequency, and elevated mechanical power, should be considered critical for SILI. These results highlight the potential role of the pendelluft phenomenon and negative pressure alveolar edema in determining SILI. Recently, in a rat model of acute lung injury, Henzler and coworkers ([@bib29]) showed that ΔP[l]{.smallcaps} was more important than inspiratory effort in generating ventilator-associated lung injury during partial ventilatory support. These results are apparently contradictory to those reported in our study, but some issue might have influenced the conclusions. First, the experimental PEEP was set at 5 cm H~2~O, which, in a murine model, is comparable to higher amounts in larger animals, producing a sort of recruitment favoring a fluid-like behavior of the lung and reducing the harmful role of SB ([@bib25]). Second, the animals ventilated with a lower degree of support presented hypercapnic acidosis that might have mitigated the ventilator-associated lung injury. Furthermore, in our study, we have assessed the V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio as a surrogate of lung compliance to explore the concept of baby lung during NIV. Data show an inverse linear correlation between V[t]{.smallcaps}e/ΔP[l]{.smallcaps} ratio and inspiratory effort (Figure E4). Moreover, the time course of this index resulted in differences between those who succeeded the 24-hour NIV trial and those who failed (Figure E2C). Thus, this might justify the discrepancies in the behavior of V[t]{.smallcaps}e and inspiratory effort. Although not significantly associated with NIV failure, this index deserves further investigations in larger physiological trials.

Limitations of the Study
------------------------

Our study has several limitations. First, the number of patients might have underpowered the results obtained. In particular, the value of ΔPes changes \< 10 cm H~2~O should be confirmed in larger trials. Second, our study population was highly selected, influencing the generalization of our results. In particular, none of the patients who were successful in the 24-hour trial required further intubation, thus indicating that patients were enrolled very early in the course of the disease. Third, we did not carry out any assessment of inflammatory biomarkers. The determination of cytokine concentrations might clarify the role of vigorous inspiratory effort in exaggerating lung injury. Moreover, as patients were studied during SB, what we measured was dynamic P[l]{.smallcaps}; thus, the influence of the inspiratory and expiratory resistances on the measured pressures should be considered. Furthermore, we did not perform gastric pressure assessment, so ΔPes values may have been overestimated in the case of expiratory muscle recruitment. Finally, despite the fact that our study identifies ΔPes changes as the major and early physiological predictor of NIV failure, the evaluation of a composite parameter that takes into account the various components of the respiratory drive (including $\overset{˙}{\text{V}}$[e]{.smallcaps}, RR, inspiratory flow rate, and airway occlusion pressure) as a bundle, might be of relevant clinical importance and should be assessed in further multicenter trials. At this time, we believe that this technique produces highly reliable data if managed in centers with expertise in esophageal manometry. Notwithstanding this, an increase in its use should raise the degree of confidence in daily clinical practice.

Conclusions
-----------

Even with the limitations described, our study highlights new concepts that can be summarized as follows: *1*) patients with severe AHRF undergoing NIV may achieve harmful P[l]{.smallcaps} amounts; *2*) the magnitude of inspiratory effort during NIV is the earliest and most accurate parameter that predicts failure; *3*) the amount of inspiratory effort is not correlated with oxygenation, and the Pa~O~2~~/F[i]{.smallcaps}~O~2~~ ratio therefore cannot be used as a surrogate of ΔPes; and *4*) the significant correlation between ΔPes changes within the first 2 hours of NIV and radiographic progression at 24 hours suggest that SILI might be a potential mechanism of lung damage in these patients.

In the hypothesis of SILI as a critical factor affecting NIV failure in patients with AHRF, we found that the magnitude of inspiratory effort as assessed by ΔPes variation within the first 2 hours of NIV treatment is an early and accurate predictor of outcome at 24 hours. The clinical implications of our study suggest that monitoring Pes might help clinicians in the decision-making process (airway intubation) for patients with AHRF undergoing a NIV trial. Because of the exploratory nature of this study, findings should be confirmed in multicenter clinical trials.
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